1.38
0.73%
0.010
Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
17.04%
12.77
|
15.39 | 11.93 | 13.34 | 9.711 |
Depreciation and Amortization |
4.35%
0.154
|
0.161 | 0.164 | 0.18 | 0.194 |
Operating Income/Loss |
17.04%
-12.77
|
-15.39 | -11.93 | -13.34 | -9.711 |
Income/Loss From Continuing Operations Before Tax |
19.59%
-10.79
|
-13.41 | -9.964 | -11.28 | -7.837 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
19.59%
-10.79
|
-13.41 | -9.964 | -11.28 | -7.837 |
Net Income/Loss
|
19.59%
-10.79
|
-13.41 | -9.964 | -11.28 | -7.837 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
71,799%
136.61
|
0.19 | 127.42 | 126.73 | 126.38 |
Basic Earnings Per Share |
20.00%
-0.08
|
-0.10 | -0.08 | -0.09 | -0.06 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):